Helping leading pharmaceutical companies spend smarter
Fair Isaac is bringing novel strategies to pharmaceutical companies looking for new ways to improve marketing effectiveness and performance. These strategies are supported by Fair Isaac's Enterprise Decision Management solutions. EDM offers a scientific approach to decision-making, reshaping the yield curve of pharmaceutical sales and marketing investments. EDM supports precise, flexible and consistent decision making across multiple channels, audiences and product lines.
Mastering complex decision making
In this era of increased expectations and accountability, day-to-day decisions about customers and resources affect success as much as product pipelines. Top pharmaceuticals use Enterprise Decision Management to improve a variety of decisions:
- What is the best approach to optimize our investments across consumer and healthcare professional programs and brands?
- How can we determine the optimal investment levels for sampling strategies?
- How will we translate our brand strategies into multichannel marketing programs with personalized, relevant messaging?
- What methodology can we use to ensure compliance across strategies and regulatory environments?
Fair Isaac's Pharmaceutical Practice provides comprehensive solutions for precise, data-driven, strategic and operational decisioning in pharmaceutical sales and marketing:
Relationship Marketing Strategy Operations and Database Management - Once you know whom to target, how to reach them in the most effective manner, and how frequently to make contact, you can automatically convert these insights into tactical plans spanning multiple products, channels and campaigns.
Professional Promotion Mix and Sample Optimization - Instead of applying the same promotional strategy to all, you can predict which prescribers will change their behaviors in response to combinations of promotional resources and allocate investments accordingly.
Aggregate Spend Solutions - Achieve regulatory compliance with current and future state-level reporting requirements by evolving from a retrospective focus of "what did we spend" to a more predictive "how and where should we spend." Increase business agility by implementing and enforcing public policy changes quickly and accurately, reducing time and costs to incorporate aggregate spend charges and accelerate development and reporting.
Interactive E-Marketing Strategies and Technologies - Leverage online marketing and enhance traditional offline marketing initiatives to reach, educate and interact with patients and physicians to create deep, profitable relationships. Deliver meaningful and differentiated tools and messages to specific, narrowly defined target markets and engage select patients and physicians in ongoing, interactive dialogues.
Product and Market Strategies - Regulatory, technology and social change are reducing ROI from traditional marketing strategies for pharmaceutical products. We're helping pharmaceutical companies innovate into far more cost-efficient and meaningful ways through development of next-generation portfolio, brand and market stragies.
Videocast:
In an era where traditional sales tactics are producing diminishing returns, pharma marketers are forced to find innovative and cost effective ways to identify, target and influence prescribers.
But where do you start?
Watch this Healthcare Practitioner Centricity Webcast now and find out.
Looking for more information on solutions for pharmaceuticals?
Visit the Resource Center to access all white papers, customer successes, and all other web-based resources related to this and many other topics.